Professor Gordon is the Chair of Anaesthesia and Critical Care at Imperial College London and an intensive care consultant based at St Mary’s Hospital. He is a Director of Research for the UK Intensive Care Society and is Chair of the NIHR Critical Care Experimental Medicine group. He is a founding member of the UK Critical Care Research Group.
His research interest focuses on translational research in sepsis. He has been an NIHR Clinician Scientist and the Chief Investigator for a number of multi-centre septic shock trials. He is now an NIHR Research Professor, leading a multi-disciplinary team investigating personalised medicine in sepsis. He is the UK Chief Investigator for REMAP-CAP, an international multi-factorial Bayesian adaptive platform trial designed for pandemic infection, including COVID-19.
Prof Anthony Gordon MD, FRCA, FFICM